Alaunos Therapeutics | ZIOP - Ordinary Share Capital


Alaunos Therapeutics reported $2.38M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Amgen USD 540M 1000K Mar/2026
AstraZeneca USD 1.55B 73K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Biogen USD 146.7M 200K Sep/2025
Bioline Rx USD 2.61B 0 Dec/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Celltrion KRW 229.65M 11.03M Mar/2026
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Intrexon USD 0 0 Jun/2024
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
J&J USD 2.41B 1.35M Mar/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 112.66M 2.35M Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Neuren Pharmaceuticals AUD 126.64M 38.63M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Pfizer USD 5.7B 13M Mar/2026
Pharma Mar EUR 17.36M 0 Mar/2026
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Qiagen NV USD 216.56M 284.67K Dec/2025
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Sartorius EUR 69.05M 0 Mar/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
TG Therapeutics USD 155.31M 95K Dec/2025
Tilray USD 116.52M 5.01M Sep/2025
Verastem USD 77.74M 77.74M Dec/2025
Zealand Pharma A/S 70.61M 319.68K Dec/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026